Thoracic RadiothErapy with Atezolizumab in Small Cell LUng CanceR Extensive Disease: a Randomized, Open-label, Multicenter Phase II Study
Latest Information Update: 05 Feb 2025
At a glance
- Drugs Atezolizumab (Primary) ; Carboplatin; Etoposide
- Indications Brain metastases; Small cell lung cancer
- Focus Therapeutic Use
- Acronyms TREASURE
Most Recent Events
- 30 Jan 2025 Status changed from active, no longer recruiting to completed.
- 30 Jun 2024 This trial has been completed in Austria, according to European Clinical Trials Database record.
- 22 Feb 2024 Planned End Date changed from 1 Jul 2024 to 1 Aug 2024.